During the past decade, Instituto do Sono conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto do Sono" #1 collaborator was "Fundação de Amparo à Pesquisa do Estado de São Paulo" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Instituto do Sono" are "Obstructive Sleep Apnea" (5 trials), "Obesity" (2 trials), "Alzheimer Disease" (1 trials), "Healthy" (1 trials) and "OSA" (1 trials). Many other conditions were trialed in "Instituto do Sono" in a lesser frequency.

Most popular intervention types in "Instituto do Sono" are "Drug" (4 trials), "Device" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "donepezil" (2 trials), "CPAP (continuous positive airway pressure)" (1 trials), "Continuous Positive Airway Pressure (CPAP)" (1 trials) and "Gabapentin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto do Sono" are 5 trials for "Male" genders and 4 trials for "All" genders.

Currently, there are NaN active trials in "Instituto do Sono". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Instituto do Sono, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto do Sono, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".